%0 Journal Article
%A Butt, Julia Anna
%A Jenab, Mazda
%A Pawlita, Michael
%A Overvad, Kim
%A Tjonneland, Anne
%A Olsen, Anja
%A Boutron-Ruault, Marie-Christine
%A Carbonnel, Franck
%A Mancini, Francesca Romana
%A Kaaks, Rudolf
%A Kühn, Tilman
%A Boeing, Heiner
%A Trichopoulou, Antonia
%A Karakatsani, Anna
%A Palli, Domenico
%A Pala, Valeria Maria
%A Tumino, Rosario
%A Sacerdote, Carlotta
%A Panico, Salvatore
%A Bueno-de-Mesquita, Bas
%A van Gils, Carla H
%A Vermeulen, Roel C H
%A Weiderpass, Elisabete
%A Quirós, José Ramón
%A Duell, Eric Jeffrey
%A Sánchez, Maria-Jose
%A Dorronsoro, Miren
%A Huerta, José María
%A Ardanaz, Eva
%A Van Guelpen, Bethany
%A Harlid, Sophia
%A Perez-Cornago, Aurora
%A Gunter, Marc J
%A Murphy, Neil
%A Freisling, Heinz
%A Aune, Dagfinn
%A Waterboer, Tim
%A Hughes, David J
%T Antibody Responses to Fusobacterium nucleatum Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer.
%J Cancer epidemiology, biomarkers & prevention
%V 28
%N 9
%@ 1538-7755
%C Philadelphia, Pa.
%I AACR
%M DKFZ-2019-02194
%P 1552 - 1555
%D 2019
%Z #EA:F022#
%X There is a lack of prospective data on the potential association of Fusobacterium nucleatum (F. nucleatum) and colorectal cancer risk. In this study, we assessed whether antibody responses to F. nucleatum are associated with colorectal cancer risk in prediagnostic serum samples in the European Prospective Investigation into Nutrition and Cancer (EPIC) cohort.We applied a multiplex serology assay to simultaneously measure antibody responses to 11 F. nucleatum antigens in prediagnostic serum samples from 485 colorectal cancer cases and 485 matched controls. Conditional logistic regression models were used to estimate odds ratios (ORs) and 95
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:31481495
%R 10.1158/1055-9965.EPI-19-0313
%U https://inrepo02.dkfz.de/record/144762